This is a fixed combination of aspirin (a blood-thinning and anti-inflammatory medicine) and atorvastatin (a cholesterol-lowering statin), used together for cardiovascular risk reduction in patients who need both an antiplatelet agent and a statin. It is a prescription-only medicine.

• Therapeutic Class: Cardiovascular risk reduction combination.

• Pharmacological Class: Antiplatelet/anti-inflammatory agent (aspirin) plus HMG-CoA reductase inhibitor/statin (atorvastatin).

• Drug Family: Combination cardiovascular prevention therapy.

• ATC Classification: Not applicable as a single combined code; aspirin alone carries N02BA01/B01AC06, atorvastatin C10AA05.

Approved/established use: Secondary prevention of cardiovascular events (heart attack, stroke) in patients with established atherosclerotic cardiovascular disease who need both antiplatelet therapy and cholesterol management.

Commonly used for: Patients with a history of heart attack, stroke, or other cardiovascular disease, or those at high cardiovascular risk needing both aspirin and a statin as part of a simplified regimen.

Off-label use (only under medical guidance): Not typically used off-label; use follows standard cardiovascular risk-reduction guidelines for the individual components.

• Oral tablets/capsules: commonly aspirin 75 mg combined with atorvastatin 10 mg, 20 mg, or 40 mg — strengths vary by brand.

Aspirin, at low doses, blocks an enzyme (COX-1) in platelets that they need to clump together and form clots, reducing the risk of a heart attack or stroke caused by a blood clot. Atorvastatin blocks an enzyme (HMG-CoA reductase) the liver needs to produce cholesterol, lowering LDL ("bad") cholesterol and helping stabilise fatty plaques in blood vessel walls, further reducing cardiovascular risk.

• Standard dose: One tablet/capsule (e.g., aspirin 75 mg/atorvastatin 10-40 mg) taken orally once daily, with food to reduce stomach irritation from the aspirin component.

• Condition-wise dose: The specific atorvastatin strength is chosen based on individual LDL cholesterol targets and cardiovascular risk, as determined by the treating doctor.

• Route: Oral, once daily, ideally at a consistent time each day; atorvastatin doses are sometimes taken in the evening, though modern formulations can be taken at any consistent time.

• Missed dose: Take as soon as remembered unless close to the next dose; don't double up.

• Overdose: May increase the risk of gastrointestinal bleeding (aspirin) or muscle/liver effects (atorvastatin); requires medical attention.

• Common: Stomach upset or mild heartburn (aspirin), and muscle aches or mild digestive upset (atorvastatin).

• Serious: Gastrointestinal bleeding or ulcers (aspirin), and, rarely, significant muscle breakdown (rhabdomyolysis) or liver enzyme elevation (atorvastatin).

• Emergency symptoms: Black or bloody stools, vomiting blood, severe unexplained muscle pain/weakness with dark urine, or yellowing of the skin/eyes.

• Recovery advice: Taking this combination with food can help reduce stomach irritation from aspirin; any new, severe, or unexplained muscle pain should be reported promptly, as it could indicate a rare but serious statin-related muscle effect.

Pregnancy: Not recommended; statins are generally avoided in pregnancy, and aspirin at this dose requires individual risk-benefit assessment.

Breastfeeding: Not recommended without specific medical guidance, particularly for the statin component.

Liver disease: Atorvastatin is generally avoided in active liver disease or unexplained persistent liver enzyme elevations.

Kidney disease: Used with caution; aspirin requires particular caution in significant kidney impairment.

Elderly: Commonly used in this age group for cardiovascular risk reduction, with routine monitoring for bleeding and muscle-related side effects.

Children: Not approved for use in children; aspirin is specifically avoided in children due to Reye's syndrome risk.

• Other anticoagulants or antiplatelet medicines (e.g., warfarin, clopidogrel): combined use increases bleeding risk.

• Strong CYP3A4 inhibitors (e.g., clarithromycin, certain antifungals): can increase atorvastatin levels, raising the risk of muscle-related side effects.

• NSAIDs: can increase gastrointestinal bleeding risk when combined with aspirin, and may also reduce aspirin's antiplatelet effectiveness if taken close together.

• Grapefruit juice: can increase atorvastatin levels and should generally be limited or avoided.

• Lipid panel periodically to assess cholesterol control.

• Liver function tests, particularly before starting and if symptoms suggest liver involvement.

• Monitoring for signs of gastrointestinal bleeding.

• Assessment for muscle pain or weakness, particularly with dose increases or added interacting medicines.

Clopidogrel (alternative antiplatelet, sometimes used instead of or alongside aspirin), Rosuvastatin, Simvastatin (other statins) — individual components can also be prescribed separately for more flexible dose titration.

This is itself a fixed combination for cardiovascular risk reduction; additional cardiovascular medicines (e.g., blood pressure medicines) are commonly used alongside as part of overall cardiovascular risk management.

• Cardiovascular Risk Reduction Medicines

• Cholesterol-Lowering Medicines (Statins)

• Antiplatelet Therapies

1. Rising cholesterol, obesity, metabolic issues among children in India

2. Six Best Foods To Lower Cholesterol

• https://www.drugs.com/search.php?searchterm=ASPIRIN%2C+ATORVASTATIN

• https://pmc.ncbi.nlm.nih.gov/articles/PMC8093790/

 The information on this page is for educational purposes only and is not a substitute for medical advice. Please consult your doctor to know if this treatment is appropriate for your condition.